Functional characterization of CDK10 and cyclin M truncated variants causing severe developmental disorders

Abstract Background CDK10 is a poorly known cyclin M (CycM)‐dependent kinase. Loss‐of‐function mutations in the genes encoding CycM or CDK10 cause, respectively, STAR or Al Kaissi syndromes, which present a constellation of malformations and dysfunctions. Most reported mutations abolish gene express...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Thomas Robert, Anne‐Catherine Dock‐Bregeon, Pierre Colas
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
Acceso en línea:https://doaj.org/article/a9b71a335ec247d798d8c68cdf527e63
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a9b71a335ec247d798d8c68cdf527e63
record_format dspace
spelling oai:doaj.org-article:a9b71a335ec247d798d8c68cdf527e632021-11-10T16:39:23ZFunctional characterization of CDK10 and cyclin M truncated variants causing severe developmental disorders2324-926910.1002/mgg3.1782https://doaj.org/article/a9b71a335ec247d798d8c68cdf527e632021-10-01T00:00:00Zhttps://doi.org/10.1002/mgg3.1782https://doaj.org/toc/2324-9269Abstract Background CDK10 is a poorly known cyclin M (CycM)‐dependent kinase. Loss‐of‐function mutations in the genes encoding CycM or CDK10 cause, respectively, STAR or Al Kaissi syndromes, which present a constellation of malformations and dysfunctions. Most reported mutations abolish gene expression, but two mutations found in 3’ exons could allow the expression of CDK10 and CycM truncated variants. Methods We built a structural model that predicted a preserved ability of both variants to form a CDK10/CycM heterodimer. Hence, we functionally characterized these two truncated variants by determining their capacity to heterodimerize and form an active protein kinase when expressed in insect cells, by examining their two‐hybrid interaction profiles when expressed in yeast, and by observing their expression level and stability when expressed in human cells. Results Both truncated variants retain their ability to form a CDK10/CycM heterodimer. While the CycM variant partially activates CDK10 activity in vitro, the CDK10 variant remains surprisingly inactive. Expression in human cells revealed that the CDK10 and CycM variants are strongly and partially degraded by the proteasome, respectively. Conclusion Our results point to a total loss of CDK10/CycM activity in the Al Kaissi patient and a partial loss in the STAR patients.Thomas RobertAnne‐Catherine Dock‐BregeonPierre ColasWileyarticleAl Kaissi syndromeCDK10cyclin Minteraction profilingprotein kinaseSTAR syndromeGeneticsQH426-470ENMolecular Genetics & Genomic Medicine, Vol 9, Iss 10, Pp n/a-n/a (2021)
institution DOAJ
collection DOAJ
language EN
topic Al Kaissi syndrome
CDK10
cyclin M
interaction profiling
protein kinase
STAR syndrome
Genetics
QH426-470
spellingShingle Al Kaissi syndrome
CDK10
cyclin M
interaction profiling
protein kinase
STAR syndrome
Genetics
QH426-470
Thomas Robert
Anne‐Catherine Dock‐Bregeon
Pierre Colas
Functional characterization of CDK10 and cyclin M truncated variants causing severe developmental disorders
description Abstract Background CDK10 is a poorly known cyclin M (CycM)‐dependent kinase. Loss‐of‐function mutations in the genes encoding CycM or CDK10 cause, respectively, STAR or Al Kaissi syndromes, which present a constellation of malformations and dysfunctions. Most reported mutations abolish gene expression, but two mutations found in 3’ exons could allow the expression of CDK10 and CycM truncated variants. Methods We built a structural model that predicted a preserved ability of both variants to form a CDK10/CycM heterodimer. Hence, we functionally characterized these two truncated variants by determining their capacity to heterodimerize and form an active protein kinase when expressed in insect cells, by examining their two‐hybrid interaction profiles when expressed in yeast, and by observing their expression level and stability when expressed in human cells. Results Both truncated variants retain their ability to form a CDK10/CycM heterodimer. While the CycM variant partially activates CDK10 activity in vitro, the CDK10 variant remains surprisingly inactive. Expression in human cells revealed that the CDK10 and CycM variants are strongly and partially degraded by the proteasome, respectively. Conclusion Our results point to a total loss of CDK10/CycM activity in the Al Kaissi patient and a partial loss in the STAR patients.
format article
author Thomas Robert
Anne‐Catherine Dock‐Bregeon
Pierre Colas
author_facet Thomas Robert
Anne‐Catherine Dock‐Bregeon
Pierre Colas
author_sort Thomas Robert
title Functional characterization of CDK10 and cyclin M truncated variants causing severe developmental disorders
title_short Functional characterization of CDK10 and cyclin M truncated variants causing severe developmental disorders
title_full Functional characterization of CDK10 and cyclin M truncated variants causing severe developmental disorders
title_fullStr Functional characterization of CDK10 and cyclin M truncated variants causing severe developmental disorders
title_full_unstemmed Functional characterization of CDK10 and cyclin M truncated variants causing severe developmental disorders
title_sort functional characterization of cdk10 and cyclin m truncated variants causing severe developmental disorders
publisher Wiley
publishDate 2021
url https://doaj.org/article/a9b71a335ec247d798d8c68cdf527e63
work_keys_str_mv AT thomasrobert functionalcharacterizationofcdk10andcyclinmtruncatedvariantscausingseveredevelopmentaldisorders
AT annecatherinedockbregeon functionalcharacterizationofcdk10andcyclinmtruncatedvariantscausingseveredevelopmentaldisorders
AT pierrecolas functionalcharacterizationofcdk10andcyclinmtruncatedvariantscausingseveredevelopmentaldisorders
_version_ 1718439902618583040